Live tape
Top 8, mentions 7d12,039SPCX2,527 mentions▲ +0.08GOOGL1,950 mentions▲ +0.02META1,905 mentions▲ +0.04TSLA1,807 mentions▲ +0.05NFLX1,015 mentions▲ +0.02QQQ1,009 mentions▲ +0.05AMZN922 mentions▲ +0.06NVDA904 mentions▲ +0.07

Equity · Healthcare

FATE

NASDAQ

Fate Therapeutics (FATE)

$2.10 −0.47% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 23, 2026

Reddit mentioned FATE 1 times in the 30 days to 25 October 2026, in 1 of the communities we track. All of them were scored for sentiment: 0% read bullish, 0% bearish and 100% neither. Reddit data updated 25 October 2026.

Price · Chart
52 sessions
$2.75 $1.75 12 Aug 23 Oct

The line runs $2.72 on 12 August through $2.10 on 23 October, on a scale from $1.75 to $2.75. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 52 sessions, 12 Aug – 23 Oct 2026
Market cap $251.6M
52-week range $0.9782 – $3.11
Avg volume 98.6K
Mentions · 30d 1

as of Oct 23, 2026

Fate Therapeutics (FATE) · crowd attention × price

Share ↗
Post on X Share on Reddit Share on LinkedIn
1 mentions

Day8 Oct 2026

MENTIONS10–2 / day
PRICE$2.13$1.75–$2.50
FATE over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed.per day012usd$1.75$2.00$2.25$2.5026 Sep3 Oct11 Oct18 Oct25 Oct
FATE over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed.26 Sep11 Oct25 Oct
The Distributed Sentinel 25 Oct 2026

FATE drew 1 Reddit mentions over the 30 days to 25 October 2026

This chart in words

The chart plots daily Reddit mentions of FATE over the 30 days to 25 October 2026: 1 in total, busiest on 8 October with 1, and 1 on the last day counted. The line is the daily close over the same window: $2.37 on 28 September, $2.10 on 23 October. Of those days, 20 were trading sessions and the other 10 are hatched on the chart. On 8 of them no session took place, and the last close before it is carried forward rather than plotted; on 2 of them no session took place, and this window holds no earlier close to carry forward.

Fate Therapeutics (FATE) on Reddit · 30d

n = 1 scored · Method

In the 30 days to 25 Oct 2026, Fate Therapeutics drew 1 Reddit mention in the finance subreddits we track, 1 of them scored for sentiment.

1 mention of FATE was scored for sentiment in these 30 days, so that one reading IS the sample. A bullish or bearish share of it could only ever read 0% or 100%, which states the sample size and not the crowd — so none is drawn. The chart on this page applies the same 5-mention floor to every day it plots.

Where FATE is discussed

(30d)
r/wallstreetbets 100% 1 +0.00

Fate Therapeutics (FATE) insider trades

SEC Form 4 · last 90 days · newest reported trade 4 Aug 2026

In the 90 days to 25 Oct 2026, Fate Therapeutics insiders reported 2 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 20 Oct 2025, show no open-market purchase.

Open-market buys 0
Open-market sells 2
Net sold $204K
Non-trade filings 0
Date Insider Type Shares Value
04 Aug 2026 TAHL CINDY See Remarks Sell 38,800 $95K
04 Aug 2026 Valamehr Bahram President and CEO Sell 43,947 $108K

Fate Therapeutics (FATE) reported financials

SEC EDGAR XBRL SEC EDGAR

Fate Therapeutics reported revenue of $6.6M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$136.3M.

Figure Reported Period
Revenue $6.6M 31 Dec 2025 fiscal year
Net income −$136.3M 31 Dec 2025 fiscal year
Diluted EPS −$1.15 31 Dec 2025 fiscal year
Total assets $260.1M 30 Jun 2026 at period end
Total equity $153.4M 30 Jun 2026 at period end

Fate Therapeutics (FATE) earnings

SEC EDGAR

Fate Therapeutics last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$0.25; no next date is announced in SEC filings yet.

Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$0.25 $2M
31 Mar 2026 Q1 2026 −$0.26 $1M
31 Dec 2025 FY 2025 −$1.15 $7M
30 Sep 2025 Q3 2025 −$0.27 $2M
30 Jun 2025 Q2 2025 −$0.29 $2M
31 Mar 2025 Q1 2025 −$0.32 $2M
31 Dec 2024 FY 2024 −$1.64 $14M
30 Sep 2024 Q3 2024 −$0.40 $3M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

Fate Therapeutics (FATE) institutional holders (13F)

SEC Form 13F SEC EDGAR

9 of the 45 institutional funds we track reported a Fate Therapeutics position for the quarter ended 30 Jun 2026 — a combined $40.4M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
AQR Capital Management Added +27.8% shares 3,837,229 $10.4M
Two Sigma Investments Held (±25%) +3.6% shares 3,589,863 $9.7M
Renaissance Technologies Held (±25%) +0.3% shares 2,983,268 $8.1M
Millennium Management New position 2,433,978 $6.6M
Citadel Advisors Held (±25%) +5.3% shares 993,308 $2.7M
Marshall Wace New position 492,426 $1.3M
Point72 Asset Management Added +925.6% shares 442,228 $1.2M
Man Group Trimmed −59.1% shares 176,107 $475K
Balyasny Asset Management New position 13,413 $36K

Fate Therapeutics (FATE) fails-to-deliver

SEC CNS data SEC

On 30 Sep 2026, 400 shares of Fate Therapeutics failed to deliver (about $952) — the latest of 3 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
30 Sep 2026 400 $952 <0.001%
29 Sep 2026 99 $236 <0.001%
28 Sep 2026 4,000 $9K 0.003%
22 Sep 2026 270 $683 <0.001%
21 Sep 2026 1,553 $4K 0.001%

Congressional trades in Fate Therapeutics (FATE)

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in Fate Therapeutics is a sale by Daniel S. Goldman (house, NY), dated 31 Jan 2023.

Date Member Type Amount
31 Jan 2023 filed 24 Feb 2023 Daniel S. Goldman house · Democrat–NY Sale $1K–$15K

Fate Therapeutics (FATE): frequently asked questions

From live data

Have Fate Therapeutics insiders bought or sold shares recently?

In the 90 days to 25 Oct 2026, Fate Therapeutics insiders reported 2 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 20 Oct 2025, show no open-market purchase.

How many institutions hold Fate Therapeutics?

9 of the 45 institutional funds we track reported a Fate Therapeutics position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

Has Fate Therapeutics had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for Fate Therapeutics is dated 30 Sep 2026, when 400 shares failed to deliver.

When did Fate Therapeutics last report earnings?

Fate Therapeutics last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$0.25; no next date is announced in SEC filings yet.

What exchange is Fate Therapeutics listed on?

Fate Therapeutics trades on NASDAQ under the ticker FATE.

What is Reddit saying about Fate Therapeutics?

Fate Therapeutics was mentioned 0 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of 1 classified mentions, 0% read bullish, 0% bearish and 100% neutral. Crowd sentiment is a social signal, not investment advice.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  5. SEC EDGARSEC EDGAR 13F filings
  6. SECSEC fails-to-deliver (CNS) data
  7. House disclosuresU.S. House of Representatives financial disclosures
  8. SEC EDGARValuation computed from SEC EDGAR filings